Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Pease DR"'
Publikováno v:
En Blanco y Negro. 1(1):1-10
El presente ensayo discute los retos y condiciones que requiere la innovación pedagógica en la educación superior a partir de la revolución provocada por la nueva ciencia del aprendizaje. La reflexión se inicia con la presentación de los proces
Externí odkaz:
http://revistas.pucp.edu.pe/index.php/enblancoynegro/article/view/2188/2118
http://repositorio.pucp.edu.pe/index/handle/123456789/117166
http://repositorio.pucp.edu.pe/index/handle/123456789/117166
Publikováno v:
En Blanco y Negro; Vol. 2, Núm. 1 (2011)
Si bien los docentes aprecian el trabajo en equipo como estrategia didáctica, su evaluación continúa siendo un reto, sobre todo atendiendo a que existe una serie de dificultades asociadas al trabajo en equipo, tales como que los estudiantes tiende
Externí odkaz:
http://revistas.pucp.edu.pe/index.php/enblancoynegro/article/view/1483/1428
http://repositorio.pucp.edu.pe/index/handle/123456789/117007
http://repositorio.pucp.edu.pe/index/handle/123456789/117007
Pese a que la formación inicial docente es uno de los elementos clave para la mejora de la calidad de la educación, son pocos los estudios que dan cuenta de cómo se forman actualmente los docentes para cumplir su labor. Los estudios internacionale
Externí odkaz:
http://hdl.handle.net/20.500.12404/12861
Lo que me interesó en la investigación fue la posibilidad de conocer a los jóvenes limenes a partir de ellos mismos, es decir entrar al tema en base a los propios actores sociales tratando de aislar las opiniones e imágenes que circulan sobre ell
Externí odkaz:
http://hdl.handle.net/20.500.12404/8082
Autor:
Chrisman LP; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL., Trimark PF; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL., Pang Y; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL., Pease DR; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL., Martinez-Escala ME; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL., Nguyen WQ; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL., Fernandez R; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL., Griffin TL; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL., Ayanruoh L; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL., Hooper MJ; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL., Zhou XA; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL., Fu L; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL., Wolniak KL; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL., Guitart J; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL.
Publikováno v:
Blood [Blood] 2024 Aug 22; Vol. 144 (8), pp. 914-917.
Autor:
Giammona A; Core Research Laboratory - Institute for Cancer Research and Prevention (ISPRO), Viale Pieraccini 6, 50139, Florence, Italy., De Vellis C; Core Research Laboratory - Institute for Cancer Research and Prevention (ISPRO), Viale Pieraccini 6, 50139, Florence, Italy., Crivaro E; Core Research Laboratory - Institute for Cancer Research and Prevention (ISPRO), Viale Pieraccini 6, 50139, Florence, Italy.; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy., Maresca L; Core Research Laboratory - Institute for Cancer Research and Prevention (ISPRO), Viale Pieraccini 6, 50139, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Viale Pieraccini 6, 50139, Florence, Italy., Amoriello R; Department of Experimental and Clinical Medicine, University of Florence, Viale Pieraccini 6, 50139, Florence, Italy., Ricci F; Core Research Laboratory - Institute for Cancer Research and Prevention (ISPRO), Viale Pieraccini 6, 50139, Florence, Italy., Anichini G; Core Research Laboratory - Institute for Cancer Research and Prevention (ISPRO), Viale Pieraccini 6, 50139, Florence, Italy., Pietrobono S; Core Research Laboratory - Institute for Cancer Research and Prevention (ISPRO), Viale Pieraccini 6, 50139, Florence, Italy., Pease DR; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA., Fernandez-Zapico ME; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA., Ballerini C; Department of Experimental and Clinical Medicine, University of Florence, Viale Pieraccini 6, 50139, Florence, Italy., Stecca B; Core Research Laboratory - Institute for Cancer Research and Prevention (ISPRO), Viale Pieraccini 6, 50139, Florence, Italy. b.stecca@ispro.toscana.it.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Aug 02; Vol. 43 (1), pp. 214. Date of Electronic Publication: 2024 Aug 02.
Autor:
Sigafoos AN; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Tolosa EJ; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Carr RM; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Fernandez-Barrena MG; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Almada LL; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Pease DR; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Hogenson TL; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Raja Arul GL; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Mousavi F; Department of Physiology and Pharmacology, University of Western Ontario, London, Canada.; Department of Oncology, University of Western Ontario, London, Canada., Sen S; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Vera RE; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Marks DL; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Flores LF; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., LaRue-Nolan KC; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Wu C; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Bamlet WR; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Vrabel AM; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Sicotte H; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Schenk EL; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Smyrk TC; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota., Zhang L; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota., Rabe KG; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Oberg AL; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Zaphiropoulos PG; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden., Chevet E; Université de Rennes, CEDEX, Rennes, France., Graham RP; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota., Hagen CE; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota., di Magliano MP; Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, Michigan., Elsawa SF; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.; Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, New Hampshire., Pin CL; Department of Physiology and Pharmacology, University of Western Ontario, London, Canada.; Department of Oncology, University of Western Ontario, London, Canada., Mao J; University of Massachusetts Medical School, Worcester, Massachusetts., McWilliams RR; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Fernandez-Zapico ME; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Jul 01; Vol. 4 (7), pp. 1677-1689.
Autor:
Paradise BD; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A.; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905, U.S.A., Gainullin VG; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A., Almada LL; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A., Sigafoos AN; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A., Sen S; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A., Vera RE; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A., Raja Arul GL; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A.; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905, U.S.A., Toruner M; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A., Pease DR; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A.; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905, U.S.A., Gonzalez AL; Facultad de Ciencias Exactas y Naturales, Instituto de Ciencias de la Tierra y Ambientales de La Pampa (INCITAP), Universidad Nacional de La Pampa - Consejo Nacional de Investigaciones Científicas y Técnicas (UNLPam-CONICET), La Pampa 6300, Argentina., Mentucci FM; Department of Pharmacy, University of Salerno, Salerno 84084, Italy., Grasso DH; Instituto de Estudios de la Inmunidad Humoral (IDEHU), Escuela de Farmacia y Bioquimica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires 1113, Argentina., Fernandez-Zapico ME; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A.
Publikováno v:
The Biochemical journal [Biochem J] 2023 Aug 16; Vol. 480 (15), pp. 1199-1216.
GLI1, a novel target of the ER stress regulator p97/VCP, promotes ATF6f-mediated activation of XBP1.
Autor:
Almada LL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Barroso K; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA; INSERM U1242, 'Oncogenesis, Stress, Signaling', Université de Rennes, Rennes, France; Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France., Sen S; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Toruner M; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Sigafoos AN; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Raja Arul GL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Pease DR; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Vera RE; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Olson RLO; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Auner HW; Imperial College London, London, UK., Pedeux R; INSERM U1242, 'Oncogenesis, Stress, Signaling', Université de Rennes, Rennes, France; Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France., Iovanna JL; Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France., Chevet E; INSERM U1242, 'Oncogenesis, Stress, Signaling', Université de Rennes, Rennes, France; Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France. Electronic address: eric.chevet@inserm.fr., Fernandez-Zapico ME; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA. Electronic address: fernandezzapico.martin@mayo.edu.
Publikováno v:
Biochimica et biophysica acta. Gene regulatory mechanisms [Biochim Biophys Acta Gene Regul Mech] 2023 Jun; Vol. 1866 (2), pp. 194924. Date of Electronic Publication: 2023 Feb 25.
Autor:
Clemens DJ; Department of Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, MN, United States of America., Ye D; Department of Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, MN, United States of America.; Division of Heart Rhythm Services, Department of Cardiovascular Medicine, Windland Smith Rice Genetic Heart Rhythm Clinic, Mayo Clinic, Rochester, MN, United States of America., Zhou W; Department of Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, MN, United States of America.; Division of Heart Rhythm Services, Department of Cardiovascular Medicine, Windland Smith Rice Genetic Heart Rhythm Clinic, Mayo Clinic, Rochester, MN, United States of America., Kim CSJ; Department of Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, MN, United States of America.; Division of Heart Rhythm Services, Department of Cardiovascular Medicine, Windland Smith Rice Genetic Heart Rhythm Clinic, Mayo Clinic, Rochester, MN, United States of America., Pease DR; Discovery Engine/Program for Hypoplastic Left Heart Syndrome, Mayo Clinic, Rochester, MN, United States of America.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States of America., Navaratnarajah CK; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States of America., Barkhymer A; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States of America., Tester DJ; Department of Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, MN, United States of America.; Division of Heart Rhythm Services, Department of Cardiovascular Medicine, Windland Smith Rice Genetic Heart Rhythm Clinic, Mayo Clinic, Rochester, MN, United States of America., Nelson TJ; Discovery Engine/Program for Hypoplastic Left Heart Syndrome, Mayo Clinic, Rochester, MN, United States of America.; Wanek Family Program for HLHS-Stem Cell Pipeline, Mayo Clinic, Rochester, MN, United States of America.; Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, United States of America., Cattaneo R; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States of America., Schneider JW; Discovery Engine/Program for Hypoplastic Left Heart Syndrome, Mayo Clinic, Rochester, MN, United States of America., Ackerman MJ; Department of Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, MN, United States of America.; Division of Heart Rhythm Services, Department of Cardiovascular Medicine, Windland Smith Rice Genetic Heart Rhythm Clinic, Mayo Clinic, Rochester, MN, United States of America.; Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, United States of America.
Publikováno v:
PloS one [PLoS One] 2023 Mar 08; Vol. 18 (3), pp. e0282151. Date of Electronic Publication: 2023 Mar 08 (Print Publication: 2023).